Integrated Stress Response in Pancreatic Beta-Cell Failure

Diabetes mellitus represents a global metabolic disorder defined by the progressive loss of pancreatic beta-cell function, resulting in insufficient insulin production and disrupted glucose homeostasis. This condition often manifests alongside insulin resistance, creating a complex pathophysiological environment that challenges therapeutic interventions. The Integrated Stress Response (ISR) has emerged as a critical signaling network capable of maintaining cellular homeostasis under both endogenous and exogenous stress conditions.

Recent research indicates that the ISR functions as a dual-edged mechanism in the context of diabetes development and progression. While transient activation of this pathway can temporarily alleviate biosynthetic stress and support cellular survival, persistent or dysregulated signaling is increasingly linked to impaired insulin secretion and loss of beta-cell identity. This dichotomy highlights the complexity of managing stress responses within pancreatic tissue.

The review synthesizes current understanding of the molecular architecture underlying ISR regulation in pancreatic beta-cells. It examines how this pathway contributes to stress biology across different diabetes subtypes, including monogenic diabetes, type 1 diabetes, and type 2 diabetes. The authors emphasize that ISR-related pathways are engaged in various forms of diabetic pathology, suggesting potential targets for therapeutic intervention.

Current therapeutic strategies targeting ISR-associated pathways remain under investigation, with significant translational challenges persisting in this field. The primary objective is to provide a theoretical foundation for understanding the molecular mechanisms driving beta-cell failure while exploring novel precision therapeutic approaches. Researchers caution that further investigation is required before clinical applications can be established.